TI
HZNP

Tidal Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Tidal Investments’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,686
Closed -$774K – 1576
2023
Q3 		$774K Buy
6,686
+1,552
+30% +$167K 0.02% 642
2023
Q2 		$528K Sell
5,134
-9,204
-64% -$971K 0.02% 788
2023
Q1 		$1.56M Buy
14,338
+4,518
+46% +$499K 0.05% 356
2022
Q4 		$1.12M Buy
9,820
+5,741
+141% +$477K 0.04% 411
2022
Q3 		$252K Sell
4,079
-1,471
-27% -$103K 0.01% 845
2022
Q2 		$443K Sell
5,550
-9,958
-64% -$943K 0.02% 635
2022
Q1 		$1.63M Buy
15,508
+10,447
+206% +$1.02M 0.05% 285
2021
Q4 		$545K Sell
5,061
-1,158
-19% -$126K 0.02% 574
2021
Q3 		$681K Buy
6,219
+382
+7% +$39.7K 0.03% 434
2021
Q2 		$547K Buy
5,837
+2,241
+62% +$206K 0.02% 410
2021
Q1 		$331K Buy
+3,596
New +$303K 0.02% 392
2020
Q3 		– Sell
-3,738
Closed -$208K – 334
2020
Q2 		$208K Buy
+3,738
New +$160K 0.03% 285

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Tidal Investments's HZNP Position: Q4 2023 in Review

Tidal Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 6,686 shares — an estimated $774K sold.

Tidal Investments first reported a position in HZNP in Q2 2020 and held it in 12 quarters. The position peaked at $1.63M in Q1 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Tidal Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Tidal Investments sold 6,686 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $774K.
  • Tidal Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 12 quarters.
  • Tidal Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.63M in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Tidal Investments's 13F filing for Q4 2023, filed 15 Feb 2024.